Number of items: 19.
Article
Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study. (2017)
Askgaard, Gro; Leon, David A; Kjaer, Mette S; Deleuran, Thomas; Gerds, Thomas A; Tolstrup, Janne S
Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. (2015)
Benova, Lenka; Awad, Susanne F; Miller, F DeWolfe; Abu-Raddad, Laith J
![]()
Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral Treatments. (2018)
Davis, Chris; Mgomella, George S; da Silva Filipe, Ana; Frost, Eric H; Giroux, Genevieve; Hughes, Joseph; Hogan, Catherine; Kaleebu, Pontiano; Asiki, Gershim; McLauchlan, John; Niebel, Marc; Ocama, Ponsiano; Pomila, Cristina; Pybus, Oliver G; Pépin, Jacques; Simmonds, Peter; Singer, Joshua B; Sreenu, Vattipally B; Wekesa, Clara; Young, Elizabeth H; Murphy, Donald G; Sandhu, Manj; Thomson, Emma C
![]()
A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. (2007)
Fraser, Abigail; Ebrahim, Shah; Smith, George Davey; Lawlor, Debbie A
Boosters for hepatitis B vaccination? Need for an evidence-based policy. (2010)
Hall, Andrew J
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. (2003)
Hellier, Simon; Frodsham, Angela J; Hennig, Branwen JW; Klenerman, Paul; Knapp, Suzanne; Ramaley, Patricia; Satsangi, Jack; Wright, Mark; Zhang, Lyna; Thomas, Howard C; Thursz, Mark; Hill, Adrian VS
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. (2004)
Kirk, Gregory D; Lesi, Olufunmilayo A; Mendy, Maimuna; Akano, Aliu O; Sam, Omar; Goedert, James J; Hainaut, Pierre; Hall, Andrew J; Whittle, Hilton; Montesano, Ruggero
The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. (2001)
Kuper, H; Ye, W; Broomé, U; Romelsjö, A; Mucci, LA; Ekbom, A; Adami, HO; Trichopoulos, D; Nyrén, O
HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. (2013)
Martin, NK; Vickerman, P; Grebely, J; Hellard, M; Hutchinson, SJ; Lima, VD; Foster, GR; Dillon, JF; Goldberg, DJ; Dore, GJ; Hickman, M
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis. (2016)
Martin, Natasha K; Vickerman, Peter; Brew, Iain F; Williamson, Joan; Miners, Alec; Irving, William L; Saksena, Sushma; Hutchinson, Sharon J; Mandal, Sema; O'Moore, Eamonn; Hickman, Matthew
HCV treatment as prevention in prison: key issues. (2014)
Martin, Natasha K; Vickerman, Peter; Goldberg, David; Hickman, Matthew
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. (2013)
Martin, Natasha K; Vickerman, Peter; Grebely, Jason; Hellard, Margaret; Hutchinson, Sharon J; Lima, Viviane D; Foster, Graham R; Dillon, John F; Goldberg, David J; Dore, Gregory J; Hickman, Matthew
![]()
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. (2011)
Martin, Natasha K; Vickerman, Peter; Miners, Alec; Foster, Graham R; Hutchinson, Sharon J; Goldberg, David J; Hickman, Matthew
Assessing the Time-Dependent Impact of Performance Status on Outcomes After Liver Transplantation. (2020)
Wallace, David; Cowling, Thomas; McPhail, Mark J; Brown, Sarah E; Aluvihare, Varuna; Suddle, Abid; Auzinger, Georg; Heneghan, Michael A; Rowe, Ian A; Walker, Kate; Heaton, Nigel; van der Meulen, Jan; Bernal, William
![]()
Conference or Workshop Item
Modelling advent of complications in primary biliary cirrhosis. (2003)
Chan, CW; Carpenter, JR; Mela, M; Patch, DW; Burroughs, AK
The Role of Common Genetic Variation around Six Candidate Loci for Susceptibility to Intrahepatic Cholestasis of Pregnancy. (2010)
Dixon, PH; Wadsworth, CA; Chambers, J; Donnelly, J; Cooley, SM; Jarvis, S; Kubitz, R; Lammert, F; Marschall, HU; Glantz, A; Khan, SA; Whittaker, J; Geary, M; Williamson, C
DOES COMMON GENETIC VARIATION AROUND THE PREGNANE-X RECEPTOR INFLUENCE SUSCEPTIBILITY TO INTRAHEPATIC CHOLESTASIS OF PREGNANCY? (2011)
Dixon, PH; Wadsworth, CA; Chambers, J; Donnelly, JC; Cooley, SM; Kubitz, R; Lammert, F; Marschall, HU; Glantz, A; Khan, SA; Whittaker, J; Geary, M; Williamson, C
Can Antiviral Therapy for Hepatitis C Reduce the Prevalence of Hcv among Injecting Drug User Populations? A Modeling Analysis of Its Prevention Utility. (2010)
Martin, NK; Vickerman, P; Foster, GR; Hutchinson, S; Goldberg, DJ; Hickman, M
A systematic review of hepatitis C virus genotypes and subtypes in G7 countries. (2004)
Pimenta, JM; Birdthistle, I; Gardner, SD; Gray, DF